ARCHIVES

Tykerb Plus Herceptin Better Than Monotherapy, Study Says

This article is from The Cancer Letter archive.

Vol. 32 No. 12 | December 25, 2009

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved By NCI Last Month Are Listed

August 29, 2003

Vaccine and LDCT Pretreatment Can Help PDACs Become Vulnerable to Immunotherapy

June 27, 2014

Centers, Groups, Others May Land in DeVita’s Office; Hammer Offers Deal congress Can’t Refuse

February 5, 1988

Avastin Approved To Treat Progressive Glioblastoma

May 29, 2009

DOD Seeks to Fund Innovative Research In 438 Million Prostate Cancer Program

August 22, 1997

Diabetes Associated With Greater Risk Of Cancer

December 28, 2007